Acute exacerbations of chronic obstructive pulmonary disease and mechanical ventilation: a reevaluation

Critical Care Medicine
J L MoranP I Leppard

Abstract

To review the intensive care unit (ICU) experience of patients admitted with acute exacerbations of chronic obstructive pulmonary disease. Retrospective case series. University teaching hospital. We reviewed the records of 100 consecutive ICU admissions of patients with acute exacerbations of chronic obstructive pulmonary disease over a period of 4.25 yrs. None. Patients were characterized using a computerized prospective database and case note review. Multivariate analysis identified variables predicting ICU and hospital length of stay. The Cox proportional hazards model was used to analyze survival after hospital discharge. Seventy-five patients (24 female and 51 male, mean age 68.5 +/- 7 [SD] yrs) with 100 ICU admissions were identified. Premorbid airway obstruction was severe, with forced expiratory volume in 1 sec (FEV1)/forced vital capacity (FVC) of 0.7 +/- 0.34 L and FEV1/FVC of 39 +/- 16%. Thirty-two percent received home-administered oxygen and 42% were housebound. The pre-ICU admission PaCO2 was 86 +/- 28 torr (11.5 +/- 3.7 kPa), with a pH of 7.24 +/- 0.11 and a PaO2/FIO2 of 190 +/- 66. ICU admission Acute Physiology and Chronic Health Evaluation II score was 18 +/- 5. Forty-three patients were mechanically ventilate...Continue Reading

References

Mar 1, 1975·American Journal of Surgery·M A GoldfarbR A Cowley
Apr 1, 1989·Statistics in Medicine·G A ColditzF Mosteller
Jan 1, 1988·Intensive Care Medicine·J L MoranM S O'Fathartaigh
Oct 1, 1985·Critical Care Medicine·W A KnausJ E Zimmerman
Feb 20, 1969·The New England Journal of Medicine·B Burrows, R H Earle
Nov 1, 1984·Critical Care Medicine·J R Le GallD Villers
May 1, 1980·Anaesthesia·I S Petheram, M A Branthwaite
Sep 28, 1995·The New England Journal of Medicine·L BrochardF Lemaire
Sep 28, 1995·The New England Journal of Medicine·M W Elliott
Feb 1, 1995·Journal of the American College of Nutrition·D H Sullivan, R C Walls
Jun 1, 1995·American Journal of Respiratory and Critical Care Medicine·N KramerN S Hill
Apr 1, 1996·Critical Care Medicine·N Abou-Shala, U Meduri
Mar 1, 1996·American Journal of Respiratory and Critical Care Medicine·K Gray-DonaldJ G Martin
Apr 1, 1996·The European Respiratory Journal·N Ambrosino
Mar 1, 1996·The European Respiratory Journal·J M Shneerson
Dec 1, 1996·Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace·N Ambrosino

❮ Previous
Next ❯

Citations

Apr 23, 2003·The Practitioner·Eric Livingston, Neil C Thomson
Nov 11, 2011·QJM : Monthly Journal of the Association of Physicians·B MesserS V Baudouin
Mar 9, 2005·Respiration; International Review of Thoracic Diseases·Gul Gursel
Aug 8, 2012·Critical Care : the Official Journal of the Critical Care Forum·Nicholas HemingChristophe Faisy
Nov 1, 2006·Critical Care Medicine·Sandra L PeakeMichaela J Walker
Feb 24, 2001·Clinics in Chest Medicine·J M Sethi, M D Siegel
May 7, 2002·Critical Care Medicine·John V PeterDavid Warn
Oct 8, 2014·Critical Care Medicine·Malcolm K RobinsonKenneth B Christopher
Sep 3, 2002·Current Opinion in Critical Care·Yin Peigang, John J Marini
May 16, 2000·Journal of the American Geriatrics Society·J LynnE P McCarthy
Dec 21, 2000·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·J Shute
Dec 23, 2004·Respirology : Official Journal of the Asian Pacific Society of Respirology·Steve YangPhilip Eng
Aug 26, 1998·Lancet·J M Madison, R S Irwin
May 19, 2006·Medicina intensiva·F Frutos-VivarUNKNOWN International Study Mechanical Ventilation Group

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.